Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Debt to Equity (2016 - 2021)

Historic Debt to Equity for International Stem Cell (ISCO) over the last 12 years, with Q2 2021 value amounting to -$0.11.

  • International Stem Cell's Debt to Equity changed N/A to -$0.11 in Q2 2021 from the same period last year, while for Jun 2021 it was -$0.11, marking a year-over-year change of. This contributed to the annual value of -$0.6 for FY2020, which is 2643.05% up from last year.
  • According to the latest figures from Q2 2021, International Stem Cell's Debt to Equity is -$0.11.
  • Over the past 5 years, International Stem Cell's Debt to Equity peaked at $2.05 during Q1 2017, and registered a low of -$14.78 during Q3 2017.
  • Moreover, its 5-year median value for Debt to Equity was -$0.17 (2020), whereas its average is -$1.09.
  • Examining YoY changes over the last 5 years, International Stem Cell's Debt to Equity showed a top increase of 16440113.64% in 2017 and a maximum decrease of 2426770.06% in 2017.
  • Over the past 5 years, International Stem Cell's Debt to Equity (Quarter) stood at -$14.78 in 2017, then skyrocketed by 104.65% to $0.69 in 2018, then plummeted by 219.31% to -$0.82 in 2019, then grew by 26.43% to -$0.6 in 2020, then skyrocketed by 81.71% to -$0.11 in 2021.
  • Its Debt to Equity stands at -$0.11 for Q2 2021, versus -$0.24 for Q1 2021 and -$0.6 for Q4 2020.